DUBLIN, March 12, 2024 /PRNewswire/ -- The "IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.

It's in the news because doctors have been trialling the drug to see if it helped treat a rare kidney condition called IgA nephropathy, also known as Berger's disease. A study published this week ...

The continued approval of Vanrafia may be contingent upon the verification of clinical benefit from the ongoing Phase III ALIGN study evaluating whether Vanrafia slows disease progression as ...